Summary:
A 2 year study to assess the safety and effectiveness of Elagolix ( shrinks uterine fibroids and decreases menstrual bleeding) in combination with a medicine for bone protection
Qualified Participants Must:
• Be 18-48 years old
•
Have heavy menstrual bleeding with diagnosis of uterine fibroids
Qualified Participants May Receive:
$50-$150 dollars per visit ( based on the number of tests performed )